SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-022505
Filing Date
2022-08-11
Accepted
2022-08-11 16:47:58
Documents
57
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls-20220630.htm   iXBRL 10-Q 1588750
2 EX-4.2 ex-42x20220630.htm EX-4.2 1517
3 EX-10.1 exhibit101-regulusx2022emp.htm EX-10.1 104440
4 EX-31.1 ex-311x20220630.htm EX-31.1 9813
5 EX-31.2 ex-312x20220630.htm EX-31.2 9790
6 EX-32.1 ex-321x20220630.htm EX-32.1 9679
12 ex-42xformofcommonstockcerb.jpg GRAPHIC 278939
13 ex-42xformofcommonstockcerc.jpg GRAPHIC 6689973
  Complete submission text file 0001628280-22-022505.txt   15898359

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20220630.xsd EX-101.SCH 37973
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20220630_cal.xml EX-101.CAL 57175
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20220630_def.xml EX-101.DEF 223477
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20220630_lab.xml EX-101.LAB 522639
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20220630_pre.xml EX-101.PRE 323967
51 EXTRACTED XBRL INSTANCE DOCUMENT rgls-20220630_htm.xml XML 951092
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 221156586
SIC: 2834 Pharmaceutical Preparations